STEREOSELECTIVE SEPARATIONS OF CHIRAL ANTICANCER DRUGS AND THEIR APPLICATION TO PHARMACODYNAMIC AND PHARMACOKINETIC STUDIES

Citation
Iw. Wainer et Cp. Granvil, STEREOSELECTIVE SEPARATIONS OF CHIRAL ANTICANCER DRUGS AND THEIR APPLICATION TO PHARMACODYNAMIC AND PHARMACOKINETIC STUDIES, Therapeutic drug monitoring, 15(6), 1993, pp. 570-575
Citations number
31
Categorie Soggetti
Pharmacology & Pharmacy","Public, Environmental & Occupation Heath",Toxicology,Biology
Journal title
ISSN journal
01634356
Volume
15
Issue
6
Year of publication
1993
Pages
570 - 575
Database
ISI
SICI code
0163-4356(1993)15:6<570:SSOCAD>2.0.ZU;2-0
Abstract
In the past few years, it has become clear that individual stereo-isom ers-especially the enantiomers-of a biologically active chiral molecul e may differ in potency, pharmacological action, metabolism, toxicity, plasma disposition, and urine excretion kinetics. This situation exis ts in all classes of therapeutically active agents including chiral an ticancer agents. The chiral compounds used in standard and experimenta l cancer chemotherapy include leucovorin (LV), ifosfamide (IFF), buthi onine sulfoximine (BSO), and verapamil (VER). Analytical methods for s tereoselective separation of each of these compounds have been develop ed and applied to pharmacokinetic and pharmacodynamic studies. Pharmac ological differences have been found between stereoisomers of all of t hese compounds and it is evident that the clinical effectiveness of th ese agents would be enhanced by the administration of only a single is omer.